FIELD: biotechnology.
SUBSTANCE: invention relates to novel dendrimer peptides and can be used in medicine. Described is a peptide dendrimer containing a branched nucleus and a set of fibrinogen-binding peptides separately covalently bonded to the branched nucleus directly or through a linker.
EFFECT: invention can be used for polymerisation of fibrinogen, as well as haemostasilogen.
34 cl, 7 dwg, 1 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HEMOSTATIC COMPOSITIONS | 2016 |
|
RU2744694C2 |
| BIOGEL | 2007 |
|
RU2503464C2 |
| PEPTIDE ANALOG OF ACYLATED OXYNTOMODULIN | 2018 |
|
RU2752787C1 |
| HAEMOSTATIC WOUND DRESSING | 2013 |
|
RU2661036C2 |
| LINKER LINKS AND MOLECULAR STRUCTURES CONTAINING THEM | 2018 |
|
RU2752671C2 |
| MODIFIED ANALOGUES OF GIP PEPTIDE | 2019 |
|
RU2817673C2 |
| PROCOAGULANT PEPTIDES, THEIR DERIVATIVES AND THEIR APPLICATION | 2012 |
|
RU2635510C2 |
| ANTIBIOTIC PEPTIDES | 2008 |
|
RU2472805C2 |
| VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2010 |
|
RU2600798C2 |
| PROLINE-RICH PEPTIDES PROTECTING AGAINST S.PNEUMONIAE | 2014 |
|
RU2737638C2 |
